Acute Lymphoblastic Leukemia Clinical Trials in Moscow
3 recruitingMoscow, Russia
Showing 1–3 of 3 trials
Recruiting
Phase 2Phase 3
Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies
Acute Myeloid Leukemia, RelapsedAcute Lymphoblastic Leukemia, High RiskAcute Myeloid Leukemia, High Risk+1 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology64 enrolled1 locationNCT07366801
Recruiting
Phase 2Phase 3
Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis
Acute Lymphoblastic LeukemiaMyelodysplastic SyndromeBiphenotypic Acute Leukemia+3 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology50 enrolled1 locationNCT06756152
Recruiting
Phase 1Phase 2
GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL
ALLB-precursor Acute Lymphoblastic LeukemiaGNR-084
AO GENERIUM36 enrolled3 locationsNCT04601584